MMTV-neu mice deficient in STAT1 are susceptible to develop ovarian teratomas

Lára Hannesdóttir1, Nina Daschil, Sonja Philipp

  • 1Division of Medical Biochemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria.

Insights

Signal transducer and activator of transcription 1 (STAT1) deficiency promotes ovarian teratoma formation in MMTV-neu mice. STAT1 may protect against teratomas by eliminating aberrant follicles, suggesting a role in later tumorigenesis.

Area of Science:

  • Oncology
  • Immunology
  • Developmental Biology

Background:

  • Signal transducer and activator of transcription 1 (STAT1) is crucial for organismal defense against pathogens and stress.
  • STAT1 is involved in innate immunity, immunosurveillance, and tumor suppression.

Purpose of the Study:

  • To investigate the role of STAT1 deficiency in ovarian teratoma development in MMTV-neu mice.
  • To determine if STAT1 impacts oocyte and follicular cell maturation.

Main Methods:

  • Examined STAT1 deficient and proficient MMTV-neu mice for teratoma development.
  • Performed conventional karyotyping on developed teratomas.
  • Compared ovarian morphology and follicular development in STAT1 deficient and proficient mice.

Main Results:

  • 9 out of 140 STAT1 deficient MMTV-neu mice developed ovarian teratomas resembling dermatoid cysts.
  • Teratomas showed diploidy without chromosomal rearrangements.
  • STAT1 deficiency promoted teratoma formation, dependent on MMTV-neu expression and genetic background (FVB/N).
  • No alterations in folliculogenesis or atresia were observed in non-tumor bearing mice, despite STAT1 presence in granulosa and theca cells.

Conclusions:

  • STAT1 deficiency promotes ovarian teratoma formation in a specific genetic context (MMTV-neu mice, FVB/N background).
  • STAT1 is not essential for normal folliculogenesis but likely plays a role in preventing teratoma formation by inducing apoptosis in aberrant follicles during later tumorigenesis stages.